ATRC
AtriCure, Inc.
NASDAQ · Healthcare · Medical - Instruments & Supplies · US
$55.53
−0.96%Year over year
Reported trailing growth
- Revenue
- +13.9%
- EBITDA
- +508.5%
- EBIT
- +140.8%
- EPS
- +127.6%
- Free cash flow
- +601.3%
- Operating cash flow
- +78.3%
Forward estimates
Based on analyst estimates
- Revenue
- +15.8%
- EBITDA
- +11.8%
- EPS
- +0.8%
Three-year CAGR
- Revenue
- +17.4%
- EBITDA
- +187.7%
- EBIT
- +91.4%
- Net income
- +74.4%
- EPS
- +74.7%
- Free cash flow
- +529.0%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026